DTL
NGM

Dynamic Technology Lab’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Dynamic Technology Lab’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,554
Closed -$63K – 1513
2023
Q1 		$63K Sell
15,554
-15,783
-50% -$72.9K 0.01% 997
2022
Q4 		$157K Buy
31,337
+9,474
+43% +$59.4K 0.02% 948
2022
Q3 		$286K Buy
21,863
+930
+4% +$14.1K 0.03% 825
2022
Q2 		$268K Buy
+20,933
New +$290K 0.03% 808

Other funds holding NGM

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Dynamic Technology Lab's NGM Position: Q2 2023 in Review

Dynamic Technology Lab sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2023, closing a stake of 15,554 shares — an estimated $63K sold.

Dynamic Technology Lab first reported a position in NGM in Q2 2022 and held it in 4 quarters. The position peaked at $286K in Q3 2022. 106 funds tracked by Wall St. Rank hold NGM as of Q2 2023.

  • Dynamic Technology Lab reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 15,554 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $63K.
  • Dynamic Technology Lab first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • Dynamic Technology Lab's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $286K in Q3 2022.
  • 106 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Dynamic Technology Lab's 13F filing for Q2 2023, filed 14 Aug 2023.